JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia (Q58023970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Alwin Krämer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andreas Reiter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jens Kruth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Philipp Erben

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Martin Müller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Amy V Jones

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Anthony D Ho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Manfred Hensel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nicholas C P Cross

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

658-660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

The Philadelphia translocation and pre-existing myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970206-1

7 January 2021

10.1016/S1470-2045(07)70206-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17613428%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference